Shaw Rietkerk

Track

Insider profile

Currently holds a position at AdaptHealth Corp.

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 91% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Revenue Officer AdaptHealth Corp. None -
Shaw Rietkerk's trades of AdaptHealth Corp.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
196.06
Quantity 44,756
Value US$4,140,554
Transaction date
Proposed sale
Price
251.17
Quantity 53,810
Value US$1,364,452
Transaction date
Sale
Price
94.72
Quantity 57,716 +30.5%
Value US$3,226,147
Transaction date
Proposed sale
Price
11.24
Quantity 25,000
Value US$281,040
Transaction date
Sale
Price
22.52
Quantity 75,000 -33.6%
Value US$1,689,060
Transaction date
Sale
Price
37.23
Quantity 55,000 -18.0%
Value US$2,047,732
Transaction date
Sale
Price
34.91
Quantity 12,000 -5.7%
Value US$418,920
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-19 2024-12-19
PrS Proposed sale
44,756
196.06
US$4,140,554 		44,756 196.06 US$4,140,554
2024-11-22 2024-11-22
PrS Proposed sale
53,810
251.17
US$1,364,452 		53,810 251.17 US$1,364,452
2024-09-24 2024-09-20
S Sale
57,716 +30.5%
94.72
US$3,226,147 		57,716 +30.5% 94.72 US$3,226,147
2024-09-20 2024-09-20
PrS Proposed sale
25,000
11.24
US$281,040 		25,000 11.24 US$281,040
2022-11-14 2022-11-10
S Sale
75,000 -33.6%
22.52
US$1,689,060 		75,000 -33.6% 22.52 US$1,689,060
2021-03-16 2021-03-12
S Sale
55,000 -18.0%
37.23
US$2,047,732 		55,000 -18.0% 37.23 US$2,047,732
2020-12-09 2020-12-07
S Sale
12,000 -5.7%
34.91
US$418,920 		12,000 -5.7% 34.91 US$418,920